Geraldine Byrne Nason

Geraldine Byrne Nason

Total lobbying returns involving this official: 29

Connections GraphMethod Pie

Official Profile

Most Recent Title
Ambassador
Most Recent Public Body
Department of Foreign Affairs
First Seen
18 January 2016
Last Seen
21 January 2026

Observed Titles

AmbassadorSecond Secretary General

Observed Public Bodies

Department of Foreign Affairs
All Lobbyists
Select methods...

Lobbying Records (Page 1 of 3)

Bayer Limited

2025-09-21

Intent: Awareness of Bayer's Crop Science division and role of the company in St. Louis and the wider US.

Details: Participation in a roundtable discussion with the Irish Ambassador to the US, organised by Greater St Louis Inc., Missouri.

Methods
Meeting

Intent: To highlight the complexity of global supply chains in the pharmaceutical industry and the risk of disruption those supply chains that tariffs may cause. ::To highlight the need for pro-business government policies that value innovation and support the continued strong footprint of innovative biopharma manufacturing in Ireland.

Details: Discuss the risks of potential tariffs on the complex global supply chains for innovative medicines

Methods
Virtual Meeting

Pfizer

2025-09-19

Intent: To highlight our concerns about the inclusion of pharmaceuticals in tariffs, the timing for entry into force, and the need for a zero-tariff pathway that includes innovative medicines. ::To highlight the potential impact of Most Favoured Nation pricing for pharmaceuticals in the US and the need for further investment in innovative medicines in Europe that recognises the value of biopharmaceutical innovation

Details: Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally

Methods
Pfizer CEO Albert Bourla met with Tánaiste Simon Harris in Dublin - MeetingEmailPhone call

Intent: Collaboration on addressing the related tariffs/trade and commercial impacts faced by the aviation and aviation finance industry.

Details: General exchange on policy developments including tariffs/trade.

Methods
16 and 21 August 2025 - Calls between AerCap (Donal Handley) and DPO - Aingeal O’Donoghue. - Phone call2 June 2025 - Meeting between AerCap (Donal Handley, Aoife MacMahon, Yvonne Devereux, Peter Juhas) and DPO - Ambassador Geraldine Byrne Nason. - Meeting20 June 2025 and 16 July 2025 - Meetings between AerCap (Donal Handley, Risteard Sheridan) and DPO - Maeve von Heynitz. - Meeting

Intent: To highlight the need for European policies that promote investment in scientific research and development, and manufacturing of innovative medicines in Europe, through strong protection of intellectual property rights and balanced environmental regulation including PFAS, Urban Waste Water Treatment Directive. ::To highlight the importance of reliable global supply chains in the pharmaceutical industry and the risk of tariffs to the disruption those supply chains.

Details: Advocate for improved EU Environment to support investment in medicines innovation and manufacturing

Methods
Event / ReceptionPhone call